

扫码开始阅读
Scan to preview the contents.
https://flbook.com.cn/c/crxNl0JhLM
Pharma Sources Insight January 2026 focuses on the following topics and more:
FROM THE EDITOR
-Enabling Productivity: Improving Speed, Success Rate and Cost in Drug Development
BRAND STORY
-Product List - Yichang Sanxia Proudin Biopharmaceutical Co., Ltd.
-SPRAY & DRY:Shanghai Ohkawara Dryers Co., Ltd.
GLOBAL PHARMA INDUSTRY
-When One Molecule Becomes a Franchise: PIP Assets in Global Pharma H1 2025
-Next-Generation Therapeutics: Global Trends and Molecular Advances
PROCUREMENT AND SALES STRATEGIES
-How ESG Turns Green Chemistry into a Commercial Advantage for Pharma
-How Suppliers Can Use Data Analytics, CRM, and AI to Win Pharma Contracts
REGULATION AND COMPLIANCE
-How to Pass your Next FDA Audit
DRUG R&D
-AI-Designed Peptide Therapeutics for Diabetes Management
PHARMA IN CHINA
-2025 H1 Panoramic Scan of R&D Investment Across 20 Domestic Innovative Pharmaceutical Companies: The Innovation Logic and Industry Transformation Behind Heavy Investment
-Hot Products and Suppliers at PharmaSources
DOWNLOAD FOR FREE
-In-depth | Global Pharmaceutical Market Research - Vietnam
INDUSTRY INSIGHT
-Is Microbial Fermentation Making a Comeback?
About Pharma Sources Insight
Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world.
Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPHI China.
【往期回顾】
点击“阅读原文”,免费阅读往期内容
第十四期:https://flbook.com.cn/c/Qviq0XDUGs
Pharma Sources Insight,
Your FREE source of news and insights into China pharmaceutical industry,
and more!
合作咨询
肖女士
021-33392297
Kelly.Xiao@imsinoexpo.com
2006-2026 上海博华国际展览有限公司版权所有(保留一切权利)
沪ICP备05034851号-57